Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)

NCT00348153 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Uveitis

Interventions

DRUG: Adalimumab

Sponsor

Heidelberg University

Collaborators

[object Object]